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Chitosan-based monoliths activated by plasma technology induced the coupling of a robust
biomimetic ligand, previously reported as an artificial Protein A, with high yields while minimizing
the environmental impact of the procedure. Due to the high porosity, good mechanical and tunable
physicochemical properties of the affinity chitosan-based monoliths, it is possible to achieve high
binding capacities (150 ¡ 10 mg antibody per gram support), and to recover 90 ¡ 5% of the bound
protein with 98% purity directly from cell-culture extracts. Therefore, the chitosan-based monoliths
prepared by clean processes exhibit a remarkable performance for the one-step capture and recovery
of pure antibodies or other biological molecules with biopharmaceutical relevance.
1. Introduction
Antibody-based biopharmaceuticals will be a major source of
new therapies for at least the next 10 years.1 The large number of
antibody products in development certainly supports the case for
optimized antibody manufacturing approaches. However, the
large quantities in which some antibody products are required
put considerable pressure on current manufacturing facilities.2,3
In particular, current purification processes are struggling to
equal the high productivities already obtained in upstream
antibody production. Affinity chromatography using Protein A
from Staphylococcus aureus is the method of choice for antibody
capture during the purification process.1 However, protein A
resins utilized in chromatography are expensive adsorbents with
low stability, often causing the leaching of the affinity ligand
together with the antibody product.1,2,4 Thus, synthetic affinity
ligands mimicking biological receptors have been developed in
an attempt to overcome Protein A drawbacks.5 Ligands based
on a triazine scaffold, in particular ligand 22/8 or artificial
protein A, and are known to be low cost and highly resistant to
the harsh conditions employed during cleaning-in-place (CIP)
and sterilization-in-place (SIP).5,6 Ligand 22/8 has been immo-
bilized on agarose,5 cellulose membranes,7 and magnetic
particles,8 and shown to selectively bind to human
Immunoglobulin G (hIgG) when employed in chromatographic
processes. With the need to treat large volumes of concentrated
antibody solutions, fast processes with high selectivity are
desired.9,10 Monoliths are porous materials cast in a single block
and inserted into a chromatography housing. These porous
supports have been successfully employed in the purification of
biological species.11–14 As convective transport is prevalent when
using monoliths, faster volumetric throughput rates are achieved
thus increasing the process speed and productivity.9
The aim of this work was to combine the robustness of
synthetic affinity ligands, namely ligand 22/8, with monolith
blocks prepared from biopolymeric materials, in particular
chitosan (CHT). In addition, sustainable chemistry options have
been adopted for the preparation and functionalization of the
materials based on freeze-drying method15,16 and plasma
technology,17,18 respectively. In particular, freeze drying pro-
cesses work by freezing the casting solution and then reducing
the surrounding pressure to allow the frozen water in the
material to sublimate directly from the solid phase to the gas
phase, resulting in attractive porous structures.19 On the other
hand, plasma technology is a fast and solvent free technique
which allows surface modification through the introduction of
chemical species.17–20 Recently, plasma surface activation was
combined for the first time with supercritical fluid technology to
surface-graft stimuli-responsive hydrogels on differently shaped
devices.21 Herein, plasma surface activation was extended to
introduce radicals on monolith surfaces for further coupling with
the affinity ligand. The materials produced have been character-
ized in terms of morphological, mechanical and physico-
chemical properties, and have shown to recover antibodies
directly from crude cell samples. Chitosan (CHT) has been
selected due to its nontoxic, antimicrobial, biocompatible, and
biodegradable properties, as well as its pH sensitive behavior.22
Owing to a high molecular weight, chitosan forms viscous
solutions in dilute aqueous acetic acid that can be used to
produce porous structures. The tensile strength of these
structures can be improved through crosslinking with epichlor-
ohydrin23 or glutaraldehyde,24 copolymerization with other
monomers, or via blending. In this work chitosan was
copolymerized (cryo-polymerization) with glycidyl methacrylate
(GMA) at low temperatures in order to produce well defined
porous monoliths with good tensile strength. Poly(vinyl alcohol)
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(PVA) was also blended with chitosan as another alternative
strategy to improve the mechanical performance of chitosan
monoliths. The processing of these renewable materials into 3D
structures with tunable and controlled morphological and
mechanical properties, large surface area and their subsequent
functionalization with a low cost affinity ligand through green
methodologies will offer a great contribution in materials design
for bioseparation processes. This integrated process aims to
replace traditional practices of monolith preparation and
functionalization by new ones where the integrity of the support
is maintained from its conception to its application even at
industrial scale.
2. Results and discussion
2.1 Preparation and characterization of native chitosan-based
monoliths
Supports for protein separation must ideally possess high
hydrophilicity, chemical and mechanical resistance, a narrow
pore size distribution, as well as enough reactive functional
groups for ligand attachment.1,9 In this work, chitosan-based
monoliths were prepared by a combination of freezing and
lyophilization methods and further evaluated according to their
morphological and mechanical properties. It is known that the
macromolecular morphology of monoliths is influenced by
the conditions employed during their preparation—in general,
the freezing and lyophilization processes generate open pore
microstructures with a high degree of interconnecting pores in
the composite materials. Large pores and high interconnectivities
contribute to high fluxes across the materials and faster
bioseparation processes.15
Native monoliths prepared only with chitosan (CHT_N)
present regular and spherical pores (data not shown); the
addition of PVA facilitates the formation of monoliths (CP_N)
with large and semi-spherical pores (Fig. 1A), while the
copolymerization with GMA (CG_N) enables obtaining even
larger and more elongated pores (Fig. 1B). In order to look
deeper into the porous network prepared, analysis by mercury
intrusion porosimetry was performed. The average pore size
diameter for CHT_N monoliths is 17 mm, while those of CP_N
and CG_N monoliths are 53 ¡ 5 and 123 ¡ 5 mm, respectively
(Table 1), which corroborate the conclusions taken from SEM
image analysis. The porosity values are similar for all chitosan-
based monoliths, varying between (70–75) ¡ 5%, which was
expected due to the constant temperature conditions employed
during monolith preparation. Typically, the pore size decreases
with the decrease of freezing temperature.15,16 During the
freezing process, water ice crystals are formed and separate
from the solutes which will be confined to the interstitial regions
between ice crystals. Large ice crystal formation is expected in
less viscous casting solutions and higher freezing temperatures,
and the opposite is also true.16 In this work, chitosan-based
casting solutions were frozen at 280 uC, a temperature at which
a low average pore size diameter—between 20 and 100 mm—is
obtained.9,16 This average pore size diameter is within the range
of interest for the purpose of the work. Concerning biosepara-
tion applications, monoliths with large pores and high porosities
are required to enable the fast permeation of cellular components
and proteins present in crude samples.25 Therefore a delicate
balance between pore size diameter, porosity and surface area is
needed during monolith design. If monoliths have larger pores
(¢150 mm) the surface area available for further functionaliza-
tion decreases, leading to a low density of the affinity
ligand.9,16,26 Also, a decrease of specific surface area with
increasing average pore size diameter is expected. The monoliths
inner surface area (total pore area) is in the range of values of
similar 3D porous structures reported in the literature.25 The
permeability and the compressive modulus of native chitosan-
based monoliths are included in Table 1. The highest perme-
ability value is registered to CG_N monolith, 390 L m22 h21
atm21, followed by CP_N and CHT_N monoliths with perme-
ability values of 294 and 142 L m22 h21 atm21, respectively.
These results indicate a clear concordance between the perme-
ability of the materials and their morphological properties and
also a good interconnectivity between the pores. The density of
the dried and wet chitosan-based monoliths (Table 1), was
calculated by measuring the weight and dimensions of the
prepared materials. Dried native chitosan-based monoliths
present similar values of density. Wet native monoliths also
showed similar densities although 50 times greater than the dried
ones due to their huge water uptake ability. The compressive
mechanical properties were studied by uniaxial compression
measurements also under dry and hydrated conditions. The
compression modulus (kPa), given by the slope of stress–strain
curves, translates the material stiffness (Table 1). In general, a
high compression modulus indicates a stiffer material.27 Native
CHT-based monoliths present lower compression modulus
values when compared to the functionalized materials. In more
detail, CP_N monoliths at different stages, wet or dry, always
present higher values of compression modulus than CG ones.
The hydrated CG_N monolith exhibits a huge swelling and
consequently becomes fragile, losing the initial integrity. These
results are consistent with the morphological and mechanical
Fig. 1 SEM images of chitosan (CHT) based-monoliths before and
after functionalization with the ligand 22/8: (A) CP_N, native monolith
prepared from chitosan and polyvinyl alcohol; (B) CG_N, native
monolith prepared from chitosan and glycidyl methacrylate; (C)
CP_22/8, functionalized CP monolith and (D) CG_22/8, functionalized
CG monolith. All the images have a magnification of 300 and the scale
bar in white indicates 10 mm.



























properties previously discussed—supports with lower average
pore size diameter and porosity are more rigid and present higher
compression modulus. It is also known that the compression
modulus of porous structures prepared at higher freezing
temperatures (e.g. 230 and 220 uC) are lower than those
prepared at 280 uC, due to the smaller pore size attained at this
temperature.25 Other factors that can influence the support
stiffness is the water absorption ability, and the proof of it is the
dramatic decrease of mechanical properties observed for mono-
liths in the hydrated sate.
2.2 Preparation and characterization of affinity chitosan-based
monoliths
Several methodologies for affinity monoliths activation and
ligand coupling have been described by diverse authors.9,24
Herein the functionalization of chitosan monoliths with a
triazine-based ligand (ligand 22/8) followed two different
strategies. The first one was based on the optimized procedure
for agarose5 and was also applied to cellulose membranes7 due to
the similarity in the chemical composition of these supports,
namely the high content of free hydroxyl groups.
Native chitosan-based monoliths were activated with epi-
chlorohydrin in order to add epoxide functionality for sub-
sequent amination. As this epoxyactivation procedure occurs
through the reaction of epichlorohydrin with free OH groups,
the density and availability of OH groups determine the
extension of the epoxide functionality achieved. The epoxy
activation yielded densities for CHT, CP and CG were 187 ¡ 51,
226 ¡ 72 and 364 ¡ 100 mmol g21 of moist monolith,
respectively. These epoxy densities are significantly higher than
those reported in the literature for agarose (50 mmol of epoxy per
gram of moist weight gel)5 and for cellulose membranes (130 ¡
10 mmol of epoxy per gram of moist membrane). The second
strategy consisted of the activation of native chitosan-based
monoliths by argon (Ar) plasma treatment. Plasma treatment is
a solvent free technique which allows the surface modification
according to the gas and power applied.17 In this work, Ar
plasma treatment introduced radicals onto the chitosan materials
for subsequent reaction with 1,6-diaminohexane. The latter acts
as a spacer arm3,5 between the surface of the epoxy or plasma
activated chitosan-based monoliths and the small biomimetic
ligand 22/8, contributing to an optimal interaction between the
ligand and the target protein (Scheme 1)
The amination values achieved were significantly higher for all
chitosan-based scaffolds activated by plasma treatment
(Table 2). The maximum amount of amines introduced using
epoxy activated chitosan-based monoliths was 364 ¡ 50 mmol
g21 support. In marked contrast, using the new approach based
on plasma surface activation this value increased almost 5-fold
(1747 ¡ 47 mmol g21 support). Due to these remarkable yields of
amination, chitosan-based monoliths activated by plasma treat-
ment were subsequently coupled with ligand 22/8. This ligand
was prepared following the procedure described by Lowe et al.5
and was immobilized onto the aminated chitosan-based mono-
liths still containing a labile chloride on the triazine ring for
nucleophilic substitution. Different yields of ligand immobiliza-
tion were obtained (Table 2), according to the monolith
materials. Although the highest value of ligand immobilization
was obtained for the CP monolith, 910 ¡ 17 mmol g21 support,
however CG monolith also presented a very high functionaliza-
tion ratio, 677 ¡ 24 mmol g21 support. The different ligand
densities on CP and CG monoliths can be related with the
surface area available in each support. CP monoliths have a
smaller pore size diameter and porosity than CG monoliths
suggesting that CP supports have higher surface area available
for further functionalization. These facts contributed to a
decrease of possible active sites in CG monoliths and conse-
quently to lower ligand density compared to the CP ones. In this
work, the density of ligand 22/8 immobilized in chitosan-based
monoliths was 10-fold the value reported for ligand 22/8
immobilized in agarose beads,5,6 70-fold on cellulose mem-
branes,7 and less than 2-fold on magnetic nanoparticles.8 It can
also be noted that, in general, the density of immobilized ligand
22/8 is quite high when compared to the values obtained for
immobilized natural ligands.23,28 To the best of our knowledge,
this is the first report on the preparation of affinity monoliths
with such a high ligand density. After ligand 22/8 immobiliza-
tion, the morphological and mechanical properties of chitosan-
based monoliths were evaluated. SEM images represented in
Scheme 1 Schematic showing the functionalization strategy of chitosan-
based monoliths with ligand 22/8 using non-thermal plasma surface
activation.
Table 1 Morphological and mechanical characterization of chitosan-based monoliths before and after functionalization with ligand 22/8. All data was
obtained from triplicated measurements
Monolith
Average pore






(L m22 h21 atm21)
Density 61023 (g cm23) Compressive Modulus (kPa)
Dry Wet Dry Wet
CP_N 53 ¡ 5 70 ¡ 5 1.3 ¡ 0.1 294 ¡ 15 4 ¡ 2 165 ¡ 10 0.41 ¡ 0.5 0.2 ¡ 5
CG_N 123 ¡ 5 75 ¡ 5 0.9 ¡ 0.1 390 ¡ 5 3 ¡ 2 177 ¡ 5 0.26 ¡ 0.5 n.a.b
CP_22/8 45 ¡ 5 68 ¡ 5 2.3 ¡ 0.2 123 ¡ 15 3 ¡ 2 146 ¡ 5 14 ¡ 5 9 ¡ 4
CG_22/8 85 ¡ 10 60 ¡ 10 1.5 ¡ 0.2 323 ¡ 10 5 ¡ 2 131 ¡ 10 8 ¡ 2 4 ¡ 2
a Determined for dried monoliths by mercury porosimetry analysis. b n.a. The mechanical assay was impossible to perform due to the high swelling
of CG_N.



























Fig. 1C and D show that the porous network and architecture
did not change significantly after the functionalization procedure
proving the potential of the new strategy developed in this work.
The average pore size diameter, porosity and surface area values
obtained for affinity CP_22/8 and CG_22/8 monoliths registered
in Table 1 were kept approximately within the combined
experimental errors. Permeability values obtained for CP and
CG monoliths decreased from 294 to 123 L m22 h21 atm21 for
CP_22/8, and from 390 to 323 L m22 h21 atm21 for CG_22/8
monoliths. The flow reduction can be explained by the presence
of the affinity ligand which confers a hydrophobic character to
the supports. However, it should be noted that the permeability
still shows the target values for separation processes whilst
allowing enough residence time for the contact between the
protein and the support.3 The apparent density of dried affinity
monolithic supports did not change compared to the native ones
at the same conditions, while wet monoliths showed a slight
increase.
After functionalization, CP_22/8 and CG_22/8 registered a
decrease in density values which can be also explained by the
hydrophobic nature of ligand 22/8 leading to a reduction in
water uptake capability. The compressive modulus increased
(y10-fold) for all monoliths after ligand coupling (refer to
Table 1). The improvement of the monolith mechanical proper-
ties whether in dry or wet conditions was expected as the
incorporation of a synthetic ligand confers rigidity and robust-
ness to the monoliths.
Therefore, the sustainable functionalization strategy of the
monoliths based on plasma activation and further ligand 22/8
coupling is able to keep most morphological properties of the
native supports while improving their mechanical properties.
In order to evaluate the stability of the affinity monoliths at
typical operating conditions used during purification processes,
monoliths were incubated at several pH solutions (from pH 1 to
12), corresponding to those employed in equilibration, elution,
regeneration and cleaning-in-place of chromatographic matrices.
The amount of ligand released from the support was monitored
(Fig. 2). The maximum amount of ligand 22/8 released from
CP_22/8 and CG_22/8 was 12% and 7%, after 4 and 2 h of
incubation, respectively (Fig. 2A and C). In particular, at the pH
conditions used in the binding and elution of antibodies from
ligand 22/8 supports, pH 3 and 8 respectively, the greatest
amount of ligand leaching was observed after 2 and 4 h, for
CP_22/8 and CG_22/8. In general, the maximum time of
monolith exposure to these conditions during a typical purifica-
tion run is 30 min, far below the threshold time for ligand
leaching, which was only observed after 2 h of exposure. On the
other hand, the highest loss of ligand from CP_22/8 and CG_22/
8 occurs with sodium hydroxide solutions after 2 h (Fig. 2B and
D). Nevertheless the maximum contact time of each functiona-
lized monolith at these harsh conditions (CIP conditions) is
Table 2 Functionalization of monoliths with amine groups using either the traditional or the plasma activation routes and surface density of affinity
ligand achieved by non-thermal plasma activation of the supports
Monolith
Epoxy activation Plasma activation Plasma activation
[NH2] (mmol g
21 support) [NH2] (mmol g
21 support) Ligand 22/8 immobilization (mmol g21 support)
CP 226 ¡ 72 1747 ¡ 47 910 ¡ 17
CG 364 ¡ 100 906 ¡ 246 667 ¡ 24
Fig. 2 Stability evaluation of CP_22/8 (A and B) and CG_22/8 (C and
D) monoliths immersed over 12 h in solutions typically used during
cleaning-in-place (CIP) procedures, including solutions with pH values
between 1 and 12. All data was obtained from duplicated measurements
with errors of ¡5.



























about 10–20 min, the time at which no ligand release was
registered.
2.3 Evaluation of affinity monoliths for antibody purification
To evaluate the affinity constants for hIgG and BSA on native
and functionalized chitosan-based monoliths, static partition
equilibrium measurements were performed in duplicate. To
attain the equilibrium between proteins and affinity supports,10
partition equilibrium studies were performed in a batch system
over 12 h, varying the protein concentration.
The experimental data was fitted using a Langmuir–
Freundlich isotherm that is the indicated model for porous
structures with heterogeneous morphology. Different affinity
constants (Ka), theoretical maximum capacity (Qmax) and
Langmuir–Freundlich coefficients (n) were obtained (Fig. 3)
with an error of ¡0.5, ¡40.0 and ¡0.1, respectively. The
affinity monoliths always presented higher values of Ka and Qmax
(14 and 3-fold, respectively) when compared to the native ones.
The CG_22/8 monolith registered the highest value of Ka and
Qmax, 4.0 6 10
4 M21 and 590 mg hIgG g21 support,
respectively. Calculated Ka values exhibit the same order of
magnitude usually obtained for similar affinity devices fitted
with Langmuir–Freundlich isotherm.27,28,31 In addition, Ka
values obtained for CP_22/8 and CG_22/8 are an order of
magnitude lower than the Ka values reported for agarose,
5
magnetic nanoparticles8 and cellulose membranes7 functiona-
lized with ligand 22/8 and fitted with a Langmuir isotherm
model. It should be remarked that values of Ka in a range
between 104 and 106 M21 indicate a medium affinity interaction,
considered optimal for bioseparation processes while facilitating
protein recovery. The values of Qmax for CP_22/8 and CG_22/8,
475 and 590 mg hIgG g21 support respectively, are 2-fold those
for agarose5 and magnetic particles8 functionalized with ligand
22/8, and very close to the one obtained for cellulose membrane.7
Values of Langmuir–Freundlich coefficients higher than 1 (n > 1)
were registered for all functionalized monoliths suggesting a
positive cooperativity in binding (attractive forces due to lateral
interactions) and a heterogeneous nature of protein adsorption.
The cooperativity depends on the macromolecular nature and
multiple functional groups, which usually results in multiple
interactions.27,28 It should be noted that the same adsorption
assays were performed with bovine serum albumin (BSA), a
model contaminant protein of antibodies in serum and cell
culture supernatants and none of the tested isotherms could fit
the experimental data. This result indicates a nonspecific
adsorption of BSA.
The dynamic binding capacity of a stationary phase is one of
the most critical factors to evaluate its chromatographic
performance. To assess the mass transfer and dynamic binding
properties of the affinity monoliths, breakthrough curves of
purified human IgG were measured in duplicates for two flow
rates (Fig. 4), as the binding capacities and elution efficiency of
supports are affected by the residence time on the monolithic
chromatographic column.
Both supports, CP_22/8 and CG_22/8, duplicated the binding
and elution capacities when the flow rate decreased from 2 to 1
mL min21 (Fig. 4). The estimated binding capacities for CP_22/8
and CG_22/8 were 57 ¡ 10 and 15 ¡ 5 mg hIgG g21 support
respectively, when using a flow rate of 2 mL min21 and 110 ¡ 15
and 26 ¡ 8 mg hIgG g21 support for a flow rate of 1 mL min21,
respectively. The elution capacity for CP_22/8 and CG_22/8
increased from 40 to 90 ¡ 5% and from 30 to 60 ¡ 5% when the
flow rate decreased from 2 to 1 mL min21.
Fig. 3 Langmuir–Freundlich adsorption isotherms for (A) CP and (B)
CG monoliths: (r) native and (m) functionalized. (C) summarizes the
estimated parameters of the Langmuir–Freundlich isotherms and
standard errors for CP and CG monoliths before and after functionaliza-
tion with ligand 22/8.
Fig. 4 Breakthrough profiles for human IgG upon (A) CP_22/8 and
(B) CG_22/8 monoliths at different flow rates: (r) 1 mL min21 and (m)
2 mL min21.



























2.4 Optimization of an affinity monolith for antibody recovery
Due to the promising morphological, mechanical and physico-
chemical properties, high stability at different pH conditions and
high static and dynamic binding capacities towards human IgG,
CP monoliths were selected for the optimization of IgG
purification process. In order to evaluate and enhance the
efficiency of affinity CP monoliths for antibody capture and
recovery, three consecutive chromatographic cycles and a fourth
one after monolith autoclaving (After_AC) were performed in
duplicates at two different flow rates, 2 and 1 mL min21. BSA,
the model contaminant, was used as a control in the same
experiments in order to evaluate the selectivity and affinity of
CP_N and CP_22/8 towards hIgG. CP monoliths exhibited
different performances on capturing and eluting hIgG and BSA
(Fig. 5 and Fig. 6).
In detail, Fig. 5A and B show that CP_N has approximately
the same low capacity to capture and elute hIgG and BSA over
the four cycles, suggesting residual non-specific interactions
between the support and the proteins. In marked contrast, the
functionalized CP_22/8 monoliths showed a substantial increase
in binding and elution capacity towards hIgG (Fig. 5C) while
only a negligible amount of BSA was retained (Fig. 5 D).
Although presenting affinity and selectivity to hIgG molecule,
the affinity monoliths lost their capacity for re-utilization,
especially after autoclaving which is translated by a slight
decrease in the bind and elution values. At these operational
conditions, CP_22/8 loses around 20% of capacity after 3
chromatographic cycles, and 50% after autoclaving (Fig. 5C).
On the other hand, only 25% of the captured hIgG was
recovered in the elution step, whereas 75% was washed during
the regeneration step under extremely harsh conditions deleter-
ious for the protein. Subsequent assays, performed at a lower
flow rate (1 mL min21), allowed an increase of the residence time
and the achievement of affinity equilibrium between the attached
ligand and the receptor in the solution (Fig. 6). Comparing the
chromatographic runs showed in Fig. 5C and 6C, it is clear that
CP_22/8 exhibited a great improvement in the binding and
elution of hIgG as only reducing the flow rate to a half led to an
over 3-fold increase of captured and eluted hIgG, 150 ¡ 10 and
135 ¡ 5 mg g21 support, respectively. Consequently, the amount
of hIgG recovered during the regeneration step was significantly
reduced, 10 ¡ 5 mg g21 support. The bind and elution capacity
of the monoliths was maintained with a slight decrease after
autoclaving (a decrease of 15%). This remarkable performance of
monoliths for recovering IgG using the flow rate of 1 mL min21
led to results that depart considerably from the reported
outcomes obtained with affinity membranes, particles and other
monoliths used in antibody purification.5,7,8,26,29
The most critical part of the study was to evaluate the direct
capture of monoclonal antibodies (Mabs) from a non-clarified
homogenate. Fig. 7 presents the chromatogram of non-clarified
crude extract of Mabs using CP_N and CP_22/8 monoliths (A)
as well as the SDS-PAGE gel,32 revealed using Coomassie Blue
R-250, obtained from the recovered samples during the
chromatographic experiment (B). The chromatogram obtained
from crude extract sample shows that CP_N did not capture any
protein (Fig. 7A) while the affinity monolith CP_22/8 captured
61 ¡ 10% of Mabs from a mammalian crude extract with
initially 1.3 mg of total protein per millilitre and eluted 80 ¡ 8%
of bounded protein. When considering the purity of the samples,
the flow-through (3) and the wash (4) contained contaminant
proteins and antibody, while the elution fractions (5,6) showed a
high purity of the antibody (estimated as 98% by ImageJ
analysis). These results confirm the efficacy of CP_22/8 in
capturing and eluting Mabs with great purity from a real crude
extract.
3. Conclusions
Herein we report for the first time the preparation of chitosan-
based monoliths by combining a freeze drying process with
surface activation by plasma treatment to modify them with a
robust biomimetic affinity ligand, previously reported as an
artificial Protein A for antibody purification. It was demonstrated
Fig. 5 Evaluation of chromatographic performance for (A, B) native
and (C, D) functionalized CP monoliths using pure IgG and BSA
solutions, respectively. The chromatographic procedures (bind, elution
and regeneration steps) were performed consecutively along four cycles at
a flow rate of 2 mL min21. The last cycle was performed after
autoclaving (After_AC).
Fig. 6 Evaluation of chromatographic performance for (A, B) native
and (C, D) functionalized CP monoliths using pure IgG and BSA
solutions, respectively. The chromatographic procedures (bind, elution
and regeneration steps) were performed consecutively along four cycles at
a flow rate of 1 mL min21. The last cycle was performed after
autoclaving (After_AC).



























that the morphological and mechanical properties of monoliths
can be tuned according to the polymer blend composition, while
the new strategy to couple the affinity ligand was able to improve
the chemical and physical stability towards the final application.
The functionalization strategy based on plasma activation proved
to be safer and more efficient than traditional activation
procedures which involve multiple steps and innumerous organic
solvents. The main practical advantages of the strategy described
are that by fast and solventless plasma activation of different
substrates, a direct procedure of functionalization could be
applied leading to robust affinity monoliths able to selectively
capture and elute antibodies even from homogenate crude
extracts. Preliminary results of monoclonal antibody (Mabs)
capture from a non-clarified homogenate suggested that CP_22/8
is able to recover Mabs with 98% purity.
A straightforward extension of the materials and functiona-
lization approach based on plasma technology herein described
can be envisaged for the production of polymeric devices with
different geometries and properties, and for the conjugation of a
wide range of biological and artificial receptors. The properties
of affinity polymeric devices can be tuned towards different
applications in addition to the example here presented. For
instance, they can find applications on the pre-concentration and
solid-phase extraction of compounds, on organo- and bio-
catalysis processes, on analytical and biosensing systems, on




Ammonium peroxodisulphate (APS, purity ¢98%), citric acid
(purity ¢99%), disodium hydrogen phosphate monodibasic (pro
analysis), disodium hydrogen phosphate dibasic (pro analysis),
disodium tetraborate, ethanol absolute and sodium citrate
dihydrate were purchased from Merck. Isopropanol and sodium
bicarbonate were purchased from Riedel-de-Haën. Acetone
(purity ¢99%), and ethyl acetate were supplied by Roth.
Acetic acid (purity ¢99%), Aminocaproic acid, 3-aminophenol,
4-amino-1-naphthol hydrochloride, cyanuric chloride (purity
¢98%), 1,6-hexanodiamine (purity ¢98%), N,N-dimethylfor-
mamide (DMF), dimethylsulfoxide (DMSO), glycine, ninhydrin,
potassium cyanide, pyridine, sodium hydroxide (purity ¢99%)
were purchased from Sigma Aldrich. Chitosan (75y85%
deacetylated, medium molecular weight), poly(vinyl alcohol)
(purity # 99%), N,N-methylenebisacrylamide (MBAm, purity
¢85%), N,N,N9,N9-tetramethylethylenediamine (TEMED, pur-
ity # 99%), bicinchoninic acid (BCA) kit, bovine serum albumin
(BSA) (purity ¢98%) were supplied by Sigma Aldrich. Human
IgG was purchased by Gammanorm (purity ¢99%).
4.2 Monoliths preparation
Chitosan-based monoliths were prepared blending different
ratios of chitosan (0–100% (wt per wt)) with PVA (0–50%) and
GMA (10%) in acetic acid aqueous solution (1% v per v). The
crosslinker agent, MBA, was also added (2% (wt per wt)) and
different casting solutions were placed in glass tubes and stirred
until homogeneous casting solutions were obtained. After the
initiator and catalyst, TEMED (23 mL) and APS (40 mL), were
added to promote the crosslinking process. The crosslinking
process occurred at 0 uC during 30 min under stirring. The
casting solutions were frozen at 280 uC during 12 h and were
lyophilized (Telstar cryodos-50) until dry.25,26
4.3 Monoliths characterization
Chitosan-based monoliths morphology was investigated using
scanning electron microscopy (SEM) in Hitachi S 2400 equip-
ment with an accelerating voltage set to 15 kV. The samples were
frozen and fractured in liquid nitrogen for cross-sectional
analysis and gold coated before analysis. Chitosan-based
monoliths porosity, average pore size diameter and surface area
were determined by mercury porosimetry (Micromeritics,
autopore IV). Water fluxes were determined at 25 uC and by
varying the applied hydrostatic pressure (within 0–0.4 MPa)
using a stainless steel high-pressure cell (with an effective volume
of 1.2 cm3). At least three measurements of distilled water flux
were performed for each monolith. The permeability (Lp) of
chitosan-based monoliths was obtained by the slope of linear
relation between flux (F) and pressure (p), and is given by Darcy
Law,7 represented by:
F = Lp 6 Dp (1)
Fig. 7 Chromatogram of Mabs purification from crude extract using
(A) CP monoliths: (r) native and (m) functionalized, at a flow rate of 1
mL min21. The fractions collected included the flowthrough (F.T.)
followed by the washing and elution steps. The acrylamide gel from SDS-
PAGE performed with the fractions collected during the Mabs
purification (B): lane 1 corresponds to the calibration proteins, lane 2
represents the loading, lane 3 is the flowthrough, lane 4 corresponds to
the first wash (phosphate buffer (50 mm, pH 8.0)), and lane 5 and lane 6
are the first and second elution fractions (sodium citrate buffer (50 mm,
pH 3.0)).



























The wet and dry densities were determined through the ratio of
wet weight as well as dry weight of the chitosan-based monoliths
with respect to their volume. The apparent density in g cm23 was








where w is the weight of monolith sample in grams, D is the
diameter of the sample in cm and H is the thickness of the sample
in cm.
Uniaxial compression was used to determine the mechanical
properties of the monoliths using tensile testing equipment
(MINIMAT firmware v.3.1) at room temperature. Samples were
prepared in a cylindrical shape (10 mm in diameter thickness).
The length between clamps was set at 5 mm, the speed set to
0 1 mm min21, a full scale load of 20 N and maximum extension
of 90 mm was used. The compression modulus was calculated









where F is the applied force, A the cross sectional area, Dl is the
change in length and L is the length between clamps. All samples
were tested in dry state at room temperature.
4.4 Monolith functionalization
The chitosan-based monoliths followed two different activation
strategies for ligand 22/8 immobilization. The first one involved
the introduction of reactive epoxy groups on monoliths by epoxy
activation. CP and CG monoliths were covered with distilled
water (10 mL), NaOH (72 mL, 0.1 M) and epichlorohydrin
(0.83 mL) and then incubated for 3 h at 35 uC on a rotary shaker
(140 rpm). After incubation, the epoxy-activated chitosan-based
monoliths were washed with distilled water (200 mL). The epoxy
activation content was determined by adding sodium thiosulfate
(3 mL, 1.3 M) to 1 gram of epoxy-activated chitosan-based
monoliths and incubating them at room temperature for 20 min.
This mixture was neutralized with HCl (0.1 M) and the amount
of HCl was registered. The volume of HCl added corresponded
to the amount of hydroxyl ions released. The second strategy
(Scheme 1) involved the use of plasma treatment which was
carried out in a radio frequency plasma reactor (Plasma system
FEMTO, version 5). Native chitosan-based monoliths were
introduced in a plasma chamber which was thoroughly purged
with a continuous flow of argon to reduce trace amounts of air
and moisture. During the treatment, the argon flow was adjusted
in order to keep a constant pressure of 0.3 Torr inside the
chamber. A power of 60 W was applied over 5 min. At the end of
the experiment the plasma chamber was ventilated and the
activated samples were immediately introduced in an aqueous
solution of hexane-1,6-diamine to be aminated. Activated
chitosan-based monoliths reacted with an excess of hexane-1,6-
diamine in water for 24 h at 45 uC, and then thoroughly washed
with water in order to remove residues of hexane-1,6-diamine
which did not react. The extent of amination was determined
using the Kaiser test. This test is a colorimetric assay to quantify
free amine groups and is based on the reaction of ninhydrin with
primary amines, which gives a characteristic dark blue color. To
perform the Kaiser test, each following reagents i) 80% crystal-
line phenol in ethanol (w/v), ii) 2% aqueous solution of
potassium cyanide (0.001 M) in pyridine (v/v) and iii) 5%
ninhydrin in ethanol (w/v) were added (50 ml of each one) to the
aminated chitosan-based monolith samples (1 mL). The samples
were then placed in a water-bath at 100 uC during 5 min. The
calibration curve was represented by standard solutions of
glycine (0–5 mmol mL21) and the absorbance measurements of
the samples (diluted 1 : 18) were performed at 560 nm. For
ligand 22/8 immobilization, an excess of ligand 22/8 (3 equiv. to
the amination content, 530 mmol, 200 mg), was added to the
aminated chitosan-based monolith samples (approximately
60 mg) in water–DMF (1 : 2). The volume of solvent used was
sufficient to cover the chitosan-based monoliths, and the
solution was incubated on a rotary shaker (140 rpm) for 72 h
at 85 uC. The synthesis of ligand 22/8 followed the procedure
described by Teng et al.5 and Barroso et.al.7 The synthesis of
ligand 22/8 was confirmed by 1H and C-NMR and FT-IR.
Functionalized chitosan-based monolith samples were then
washed with water–DMF (1 : 2) until the absorbance at
270 nm was zero.
In order to assure a complete exclusion of non-absorbed
ligands into and onto chitosan-based monoliths, functionalized
samples were introduced in a Varian column (a reservoir with
3 mL of capacity) and were submitted to several washes with
water–DMF (1 : 2) and to clean-in-place-procedure. The clean-
in-place-procedure consisted of washing functionalized chitosan-
based monoliths with NaOH (1 M) until the absorbance at
270 nm be zero, with water (10 mL), then with regeneration
buffer (NaOH 0.1 M in 30% of isopropanol) until the
absorbance at 270 nm be zero, and finally, again with distilled
water (10 mL). The functionalized chitosan-based monoliths
were equilibrated with sodium phosphate buffer (50 mM, pH
8.0) and sodium citrate buffer (50 mM, pH 3.0) until the
absorbance at 270 nm be zero. The extinction coefficient of
ligand 22/8 was determined at its maximum absorbance
wavelength (e270 = 10.72 L g
21 cm21), respectively. The ligand
22/8 density was determined by subtracting the amount of ligand
contained in all the washing liquors from the initial ligand used
in the immobilization step. The chitosan-based monoliths
containing ligand 22/8 were characterized in terms of morpho-
logical and mechanical properties as referred previously.
4.5 Static partition equilibrium experiments
Partition equilibrium experiments were performed in a batch
system as described by Barroso et al.7 The adsorption of hIgG
and BSA on the chitosan-based monoliths was investigated using
a sample of native and functionalized chitosan-based (10 mg)
monoliths varying the concentration of hIgG and BSA (0.0–
45 mg mL21, 400 mL) in phosphate buffer (50 mM, pH 8.0)
solutions. All experiments were conducted in duplicates at 25 uC,
at a stirring rate of 200 rpm during 12 h. At the end of this
period, the native and functionalized chitosan-based monoliths
were removed from the medium. The amount of adsorbed hIgG
and BSA was determined by measuring the initial and final



























concentrations of hIgG within the adsorption medium. A
calibration curve was prepared using hIgG and BSA in
phosphate buffer solutions (50 mM, pH 8.0) (0.0–45 mg
mL21). The concentration of protein was measured at 280 nm
on a microplate reader (Tecan Infinite F200, filter, l = 280 nm).
The adsorption phenomenon followed the Langmuir–Freundlich





where Kd is the apparent dissociation constant (M) that includes
contributions from ligand binding to support, Qm is the
maximum binding capacity (mg protein g21 support), C is the
concentration of protein in the liquid at the equilibrium (M) and
n represents the Langmuir–Freundlich coefficient.
4.6 Frontal Analysis—breakthrough curves and binding capacity
The dynamic loading capacity of the packed columns with native
and functionalized chitosan-based monoliths was determined





Where Q corresponds to the estimated adsorbent capacity and
Ve corresponds to the elution volume.
This technique consisted in loading hIgG and BSA solutions
(8 mL, 0.5 mg mL21) in sodium phosphate buffer (50 mM, pH
8.0) through the equilibrated monolithic packed columns at
different flow rates, 1 and 2 mL min21 until the protein
concentration of the output and input streams were identical.
Then, packed monolithic columns were washed with phosphate
buffer (50 mM, pH 8.0) and the bound protein was eluted with
sodium citrate buffer (50 mM, pH 3.0). Each collected milliliter
during loading, washing and elution steps were analyzed by
absorbance at 280 nm, using a microplate reader, in order to
estimate the amount of protein bounded and eluted.
4.7 Chromatographic experiments
In order to estimate the capacity of functionalized chitosan-
based monoliths, Varian columns (with a capacity of 3 mL and
an effective volume of 1.2 cm3) were packed with these polymeric
affinity structures. The columns were connected to a peristaltic
pump using rubber tubing in order to allow flow control. The
affinity capturing experiments were performed in a step-wise
adsorption–desorption process by switching eluents at room
temperature and at atmospheric pressure. Packed columns with
functionalized chitosan-based monoliths were loaded with 1 mL
of hIgG and BSA solution (5 mg mL21) in order to estimate the
capacity of the columns for each protein. Then, columns were
washed with sodium phosphate buffer (50 mM, pH 8.0) until the
absorbance measured at 280 nm reached ¡0.005, in order to
remove all the protein physically adsorbed. The bound protein
was eluted and recovered with sodium citrate buffer (50 mM, pH
3.0). Packed columns with functionalized chitosan-based mono-
liths were then regenerated as described above in order to be
reused. These chromatographic experiments were repeated
during 3 cycles and one more after auto-claving in order to
evaluate the column capacity over time. The total amount of IgG
bound, eluted and regenerated from the chitosan-based mono-
liths was initially determined by absorbance measured at 280 nm
and by the BCA (microplate reader assay). As the results were
consistent (data not shown) only absorbance measured at
280 nm was further used for protein quantification.
4.8 Purification of monoclonal antibodies from mammalian crude
extracts
In order to evaluate the possibility to capture directly antibodies
from non-clarified crude extracts, packed columns with native
and functionalized CP monoliths were loaded with a mammalian
crude extract solution (1 mL, 1.3 mg of total protein per
milliliter). After crude extract loading, packed columns were
washed with the sodium phosphate buffer (15 mL, 50 mM, pH
8.0) until the absorbance measured at 280 nm reached ¡0.005
and the bound protein was after eluted and recovered with
sodium citrate buffer (50 mM, pH 3.0). All collected samples
were analyzed by the BCA assay in order to quantify the amount
of total protein bound and eluted from the solid support. The
BCA assay consists in adding the BCA working reagent (200 mL)
to the samples (25 mL). The microplates were incubated in the
dark for 30 min at 37 uC. A standard curve was determined for
each assay (200–1000 mg mL21). SDS-PAGE was performed on
acrylamide gel (12.5%) in Tris-Glycine buffer system pH 8.3.
Electrophoresis apparatus (from BIO-RAD) was connected with
power supply at 120 V, 190 mA for 1 h. The staining solution
was prepared by adding 1 g of Coomassie Blue R-250, 15 ml of
glacial acetic acid, 90 ml of methanol, and deionized water until
200 ml.
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